InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,620.36
(
-1.19%
)
Post# of 6306
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BioBull1

Send PM Follow Ignore
Followers 0
Posts 56
Boards Moderated 0
Alias Born 01/11/2016

BioBull1

Re: Devo33 post# 5635

Thursday, 11/17/2016 2:40:33 PM

Thursday, November 17, 2016 2:40:33 PM

Post# of 6306
Perrin has been saying that all year regarding pace.

To conclude the INSPIRE trial by Summer 2017 would require Invivo to enroll the remaining 11 patients in the next 2 to 3 months. Don't forget, the endpoint of this trial is patient observation at the 6 month mark.

In other words, it's not going to happen. GL.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up